|
QRICH1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.979600E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.403090E-03 |
| Normal-vs-Stage2 |
8.163900E-03 |
| Normal-vs-Stage3 |
8.006900E-04 |
| Normal-vs-Stage4 |
1.955440E-03 |
| Stage1-vs-Stage2 |
4.817400E-01 |
| Stage1-vs-Stage3 |
3.972200E-01 |
| Stage1-vs-Stage4 |
5.653400E-01 |
| Stage2-vs-Stage3 |
9.439600E-01 |
| Stage2-vs-Stage4 |
8.287400E-01 |
| Stage3-vs-Stage4 |
8.455800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.361000E-03 |
| Normal-vs-AfricanAmerican |
4.351600E-01 |
| Normal-vs-Asian |
7.608200E-02 |
| Caucasian-vs-AfricanAmerican |
2.013000E-01 |
| Caucasian-vs-Asian |
5.106600E-01 |
| AfricanAmerican-vs-Asian |
4.973800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.941080E-03 |
| Normal-vs-Female |
4.780700E-04 |
| Male-vs-Female |
8.396600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.241000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.197590E-03 |
| Normal-vs-Age(61-80Yrs) |
9.378600E-04 |
| Normal-vs-Age(81-100Yrs) |
4.786100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.110200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.920600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.127800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.140400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.275400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.531000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.080300E-02 |
| Classical-VS-Follicular |
1.82670000004048E-06 |
| Classical-VS-Other |
6.938100E-02 |
| Classical-VS-Normal |
6.934300E-02 |
| Tall-VS-Follicular |
1.590390E-01 |
| Tall-VS-Other |
4.621200E-01 |
| Tall-VS-Normal |
2.260800E-03 |
| Follicular-VS-Other |
9.814000E-01 |
| Follicular-VS-Normal |
3.55910000027215E-07 |
| Other-VS-Normal |
1.353980E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.155540E-04 |
| Normal-vs-N1 |
8.603800E-04 |
| N0-vs-N1 |
7.288800E-01 |
|
|
